Autopsy report · NCT01805804
Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients
Cause of deathDrug or device supply
“Recall of some valsartan preparations. 88 patients enrolled and completed the observation. All patients are in continuous observation and are well.”
Life of this trial
- Registered 3 years 10 months before it started.
- Ran for about 2 years 1 month before it stopped.
- 88 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Medical University of Silesia
- Sponsor type
- University, hospital or other
- Conditions
- First Time Dual Chamber Pacemaker Implantation
- Interventions
- placebo/valsartan
- Participants
- 88 (planned, not actual)
- Sites
- 1
- Countries
- Poland
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.